Skip to main content



Local Cdiff information for Wisconsin

Wisconsin

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Wisconsin.



Local Cdiff information for Wisconsin

Wisconsin

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Wisconsin.

Providers

Regulation

C. diff Infections

Total Reported Cases: 1009
Hospital Onset: 1009
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.69
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: Yes
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Gwen Borlaug, CIC, MPH
Infection Control Epidemiologist
Wisconsin Department of Health Services
Division of Public Health, Bureau of Communicable Diseases
1 West Wilson Street Room 318
Madison, 53702
(608) 267-7711
(608) 261-4976
EMAIL GWEN BORLAUG, CIC, MPH >

CLINICAL TRIALS

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL >
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL >
Gender: All
Age: 18 Years and older   (Adult, Older Adult)

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.